New VigiLyze developments set to improve analysis and sharing

Signal detection / 23 October 2019

Photo: Jason Coudriet, Unsplash

The previous update of VigiLyze went live in May but there’s been no let-up in the pace of development.

The next version of VigiLyze is set to release, containing many new user- requested features, including a range of new filtering options, such as by continent and WHO region. Users can create customised filter groups and investigate disproportionality by sub-groupings. National pharmacovigilance centres will also be able to filter data using the EMA’s list of important medical events (a subset of MedDRA preferred terms) and there are new graphs and filters for Reporter, Serious, Seriousness, and Fatal. 

Jessica Nilsson, Project Manager & Business Analyst, UMC

Alongside these new features, Netherlands Pharmacovigilance Centre Lareb is helping UMC to develop a new approach to signal sharing and will be the first organisation outside UMC to share previously published signals with the network through VigiLyze. 

“From our point of view this is a new opportunity to share our signals to a wider audience in addition to our own website and newsletter,” said Florence van Hunsel, Lareb’s head of signal detection. 

“Hopefully the information will be of use to others investigating signals. In turn, we will also make use of the UMC signals available in VigiLyze for our own signal detection.” 

UMC project manager and business analyst, Jessica Nilsson, says this is an exciting development, which could strengthen collaboration in the WHO programme.

“We are striving to gather information in one place. We know that many national centres look to other agencies to find out what is going on. By sharing signals in VigiLyze, we reduce the risk of evaluating from scratch a problem that has already been evaluated by others, and at the same time we reduce the number of places the user needs to visit to get information,” Nilsson said. 

While much remains to be done, the work carried out so far represents a major step forward and has the potential to usher in a new era of enhanced collaboration between centres. 

Graeme Nadasy
Communications Officer & Editor, UMC

You may also like

Record growth pushes VigiBase past 28 million reports

After decades of slow but steady growth, VigiBase has recently entered a new phase of accelerating expansion, driven by a range of converging forces.

Signal detection / 16 September 2021

Unmasking data in the COVID-19 vaccine era – New podcast episode

What are the implications for signal detection when new approaches to reporting create greater data streams than have ever been present for older medicinal products?

Signal detection / 30 January 2023

Vaccine surveillance systems explained – new podcast episode

Ever wondered how safety surveillance differs between vaccines and drugs? Find out in the latest episode of the Drug Safety Matters podcast.

Signal detection / 25 August 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more